Middle East & Africa Artificial Intelligence In Drug Discovery Market Size & Outlook
Middle East & Africa artificial intelligence in drug discovery market, 2018-2030 (US$M)
Related Markets
MEA artificial intelligence in drug discovery market highlights
- The MEA artificial intelligence in drug discovery market generated a revenue of USD 12.7 million in 2023.
- The market is expected to grow at a CAGR of 26.6% from 2024 to 2030.
- In terms of segment, oncology was the largest revenue generating therapeutic space in 2023.
- Infectious Disease is the most lucrative therapeutic space segment registering the fastest growth during the forecast period.
- Country-wise, UAE is expected to register the highest CAGR from 2024 to 2030.
MEA data book summary
| Market revenue in 2023 | USD 12.7 million |
| Market revenue in 2030 | USD 66.3 million |
| Growth rate | 26.6% (CAGR from 2024 to 2030) |
| Largest segment | Oncology |
| Fastest growing segment | Infectious Disease |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Oncology, Neurodegenerative Diseases, Cardiovascular Disease, Metabolic Diseases, Infectious Disease, Other |
Other key industry trends
- In terms of revenue, MEA region accounted for 0.9% of the global artificial intelligence in drug discovery market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 2,165.2 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Artificial Intelligence in Drug Discovery Market Scope
Artificial Intelligence in Drug Discovery Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Middle East & Africa artificial intelligence in drug discovery market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to artificial intelligence in drug discovery market will help companies and investors design strategic landscapes.
Oncology was the largest segment with a revenue share of 22.83% in 2023. Horizon Databook has segmented the Middle East & Africa artificial intelligence in drug discovery market based on oncology, neurodegenerative diseases, cardiovascular disease, metabolic diseases, infectious disease, other covering the revenue growth of each sub-segment from 2018 to 2030.
Increasing prevalence of chronic ailments, such as respiratory disorders & heart diseases, and growing geriatric population are boosting the demand for improved healthcare facilities.
The incidence of chronic disorders, such as obesity, cardiovascular diseases, and diabetes, is increasing rapidly, owing to various factors such as sedentary lifestyle, hypertension, poor eating habits, physical inactivity, & lack of sleep.
In October, 2017, the government of UAE launched the UAE Strategy for AI, which uses an integrated digital system to provide quick & efficient solutions for the healthcare sector and minimizing the impact of chronic & dangerous diseases.
Reasons to subscribe to Middle East & Africa artificial intelligence in drug discovery market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Middle East & Africa artificial intelligence in drug discovery market databook
-
Our clientele includes a mix of artificial intelligence in drug discovery market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa artificial intelligence in drug discovery market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa artificial intelligence in drug discovery market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
MEA artificial intelligence in drug discovery market size, by country, 2018-2030 (US$M)
Middle East & Africa Artificial Intelligence in Drug Discovery Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
